Evidence map›Paper›PMID 32276415›Full record

ArticleInternational journal of molecular sciences2020

Healthspan Maintenance and Prevention of Parkinson's-like Phenotypes with Hydroxytyrosol and Oleuropein Aglycone in

Giovanni Brunetti, Gabriele Di Rosa, Maria Scuto, Manuela Leri, Massimo Stefani, Christian Schmitz-Linneweber, Vittorio Calabrese, Nadine Saul

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 2 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 2 syntheses or guidelines pooled it, 138 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Discovery of TDP-43 aggregation inhibitorsbioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Frontiers in aging neuroscience · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Giovanni BrunettiDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95125 Catania, Italy.
Gabriele Di RosaDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95125 Catania, Italy.
Maria ScutoDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95125 Catania, Italy.ORCID 0000-0003-1019-5158
Manuela LeriDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
Massimo StefaniDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
Christian Schmitz-LinneweberHumboldt University of Berlin, Faculty of Life Sciences, Institute of Biology, Molecular Genetics Group, Philippstr. 13, House 22, 10115 Berlin, Germany.
Vittorio CalabreseDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95125 Catania, Italy.ORCID 0000-0002-0478-985X
Nadine SaulHumboldt University of Berlin, Faculty of Life Sciences, Institute of Biology, Molecular Genetics Group, Philippstr. 13, House 22, 10115 Berlin, Germany.ORCID 0000-0002-6798-0918
University of Catania · ITHumboldt-Universität zu Berlin · DEUniversity of Florence · IT

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Horizon 2020 Framework Programme No 633589 (Aging with Elegans).NIH HHS P40 OD010440
6 · The paper itself

Abstract

Numerous studies highlighted the beneficial effects of the Mediterranean diet (MD) in maintaining health, especially during ageing. Even neurodegeneration, which is part of the natural ageing process, as well as the foundation of ageing-related neurodegenerative disorders like Alzheimer's and Parkinson's disease (PD), was successfully targeted by MD. In this regard, olive oil and its polyphenolic constituents have received increasing attention in the last years. Thus, this study focuses on two main olive oil polyphenols, hydroxytyrosol (HT) and oleuropein aglycone (OLE), and their effects on ageing symptoms with special attention to PD. In order to avoid long-lasting, expensive, and ethically controversial experiments, the established invertebrate model organism

Indexed as

alpha-SynucleinAcetatesAnimalsAnimals, Genetically ModifiedCaenorhabditis elegansCyclopentane MonoterpenesDisease Models, AnimalDopaminergic NeuronsParkinson DiseasePhenylethyl AlcoholPolyphenolsPyransTreatment Outcome3,4-dihydroxyphenylethanolAcetatesalpha-SynucleinCyclopentane Monoterpenesoleuropein aglyconePhenylethyl AlcoholPolyphenolsPyransageingC. eleganshealthspanlifespanolive oilParkinson’s diseasepolyphenols

Identifiers

PMID32276415
PMCPMC7178172
OpenAlexW3016215686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.